Halper Sadeh LLC Conducts Investigation into AKRO, CCRD, and PBBK for Shareholder Interests
Investigation of Companies: Halper Sadeh LLC is investigating Akero Therapeutics, CoreCard Corporation, and PB Bankshares for potential violations of federal securities laws and breaches of fiduciary duties related to their proposed sales.
Akero Therapeutics Sale: Akero shareholders are set to receive $54.00 per share in cash and a Contingent Value Right for an additional $6.00 upon regulatory approval of efruxifermin by June 30, 2031.
CoreCard Corporation Sale: CoreCard shareholders will receive an exchange ratio of Euronet common stock between 0.2783 and 0.3142 for each share they own.
PB Bankshares Sale: PB Bankshares shareholders can choose to receive either 0.7850 shares of Norwood common stock or $19.75 in cash for each share they own, with Halper Sadeh LLC offering legal support to shareholders regarding their rights and options.
Analyst Views on PBBK
About PBBK
About the author






